{"id":217106,"date":"2026-08-24T14:11:59","date_gmt":"2026-08-24T08:41:59","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=217106"},"modified":"2026-08-24T14:12:03","modified_gmt":"2026-08-24T08:42:03","slug":"natco-pharma-share-price-usfda-observations-visakhapatnam-august-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-usfda-observations-visakhapatnam-august-2026\/","title":{"rendered":"Natco Pharma Share Price Rises 0.36% to Rs 885.70 Despite USFDA Issuing Four Observations at Visakhapatnam FDF Plant"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>NATCOPHARM: Rs 885.70 (+0.36%). USFDA: 4 observations at Visakhapatnam FDF plant, Aug 17-21. Company: procedural in nature. Intraday high Rs 892.40. Aug 24, 2026.<\/em><\/p>\n<div style=\"background: #F0F9FF; border-left: 4px solid #2E7D32; border-radius: 6px; padding: 14px 18px; margin: 18px 0;\">\n<p style=\"margin: 0; color: #1f4e79; font-size: 14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin: 8px 0 0;\">Natco Pharma share price rose 0.36% to Rs 885.70 on August 24, 2026, even as the company disclosed that the US FDA issued a Form 483 with four observations following an inspection at its Finished Dosage Formulations (FDF) manufacturing plant in Visakhapatnam, Andhra Pradesh. The inspection was conducted from August 17 to 21, 2026. Natco Pharma has characterised the four observations as procedural in nature. The modest positive share price reaction, despite the FDA observations, suggests the market views this as a manageable regulatory matter.<\/p>\n<\/div>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-usfda-observations-visakhapatnam-august-2026\/#What_Is_the_Natco_Pharma_USFDA_Inspection_at_Visakhapatnam\" title=\"What Is the Natco Pharma USFDA Inspection at Visakhapatnam?\">What Is the Natco Pharma USFDA Inspection at Visakhapatnam?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-usfda-observations-visakhapatnam-august-2026\/#Natco_Pharma_Share_Price_and_Inspection_Details\" title=\"Natco Pharma Share Price and Inspection Details\">Natco Pharma Share Price and Inspection Details<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-usfda-observations-visakhapatnam-august-2026\/#Why_Did_Natco_Pharma_Share_Price_Rise_Despite_FDA_Observations\" title=\"Why Did Natco Pharma Share Price Rise Despite FDA Observations?\">Why Did Natco Pharma Share Price Rise Despite FDA Observations?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-usfda-observations-visakhapatnam-august-2026\/#About_Natco_Pharma_Business_Overview\" title=\"About Natco Pharma: Business Overview\">About Natco Pharma: Business Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-usfda-observations-visakhapatnam-august-2026\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-usfda-observations-visakhapatnam-august-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-usfda-observations-visakhapatnam-august-2026\/#What_is_the_Natco_Pharma_USFDA_inspection_at_Visakhapatnam\" title=\"What is the Natco Pharma USFDA inspection at Visakhapatnam?\">What is the Natco Pharma USFDA inspection at Visakhapatnam?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-usfda-observations-visakhapatnam-august-2026\/#What_is_Natco_Pharma_share_price_today\" title=\"What is Natco Pharma share price today?\">What is Natco Pharma share price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-usfda-observations-visakhapatnam-august-2026\/#Why_did_Natco_Pharma_share_price_rise_despite_FDA_observations\" title=\"Why did Natco Pharma share price rise despite FDA observations?\">Why did Natco Pharma share price rise despite FDA observations?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-usfda-observations-visakhapatnam-august-2026\/#What_is_a_Form_483_in_FDA_inspections\" title=\"What is a Form 483 in FDA inspections?\">What is a Form 483 in FDA inspections?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-usfda-observations-visakhapatnam-august-2026\/#What_is_Natco_Pharmas_business\" title=\"What is Natco Pharma&#8217;s business?\">What is Natco Pharma&#8217;s business?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-usfda-observations-visakhapatnam-august-2026\/#Is_Natco_Pharma_a_good_buy_after_the_USFDA_observations\" title=\"Is Natco Pharma a good buy after the USFDA observations?\">Is Natco Pharma a good buy after the USFDA observations?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Is_the_Natco_Pharma_USFDA_Inspection_at_Visakhapatnam\"><\/span><strong>What Is the Natco Pharma USFDA Inspection at Visakhapatnam?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The US Food and Drug Administration conducted an inspection at <a href=\"https:\/\/univest.in\/stocks\/natcopharm\/natco-pharma-ltd-share-price-today\">Natco Pharma<\/a>&#8216;s Finished Dosage Formulations (FDF) manufacturing plant located in Visakhapatnam, Andhra Pradesh, from August 17 to August 21, 2026. Following the inspection, the US FDA issued a Form 483 with four observations. Natco Pharma has stated that the observations are procedural in nature.<\/p>\n<p>A Form 483 is issued by the FDA at the conclusion of an inspection when investigators observe conditions that may constitute violations of the Food, Drug, and Cosmetic Act. The company now has the opportunity to respond to the FDA with corrective action plans within the standard response timeline.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=natco-pharma-usfda-visakhapatnam\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Natco_Pharma_Share_Price_and_Inspection_Details\"><\/span><strong>Natco Pharma Share Price and Inspection Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"border-collapse: collapse; width: 100%;\" border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr style=\"background: #1F4E79; color: #ffffff;\">\n<th>Parameter<\/th>\n<th>Detail<\/th>\n<\/tr>\n<tr>\n<td>Facility Inspected<\/td>\n<td>FDF Manufacturing Plant, Visakhapatnam, Andhra Pradesh<\/td>\n<\/tr>\n<tr>\n<td>Inspection Dates<\/td>\n<td>August 17 to 21, 2026<\/td>\n<\/tr>\n<tr>\n<td>Regulatory Document Issued<\/td>\n<td>Form 483<\/td>\n<\/tr>\n<tr>\n<td>Number of Observations<\/td>\n<td>Four<\/td>\n<\/tr>\n<tr>\n<td>Nature of Observations<\/td>\n<td>Procedural (per company disclosure)<\/td>\n<\/tr>\n<tr>\n<td>CMP (24 Aug)<\/td>\n<td>Rs 885.70 (+0.36%)<\/td>\n<\/tr>\n<tr>\n<td>Intraday High<\/td>\n<td>Rs 892.40<\/td>\n<\/tr>\n<tr>\n<td>Intraday Low<\/td>\n<td>Rs 876.90<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Why_Did_Natco_Pharma_Share_Price_Rise_Despite_FDA_Observations\"><\/span><strong>Why Did Natco Pharma Share Price Rise Despite FDA Observations?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Natco Pharma share price rising 0.36% despite the disclosure of FDA observations reflects the market&#8217;s assessment that procedural Form 483 observations are a routine and manageable part of operating in the heavily regulated US generics and pharmaceutical export business. Unlike a Warning Letter or an Official Action Indicated (OAI) classification, procedural observations at the Form 483 stage typically do not disrupt ongoing manufacturing operations or export approvals from the facility in question.<\/p>\n<p>Investors should note that trading volume today was 28,276 shares, slightly below the five-day average of 30,983 shares, an 8.74% decrease, suggesting the market has not reacted with elevated urgency to the FDA disclosure.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Screen Natco Pharma on Univest Screener for USFDA Compliance Track Record<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"About_Natco_Pharma_Business_Overview\"><\/span><strong>About Natco Pharma: Business Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Natco Pharma is a leading Indian pharmaceutical company known for its complex generics portfolio, oncology drug franchise, and active pharmaceutical ingredient (API) manufacturing capabilities. The company has multiple manufacturing facilities across India that are certified by the US FDA and other global regulatory bodies, supplying finished dosage formulations to the US and other regulated markets. Given the importance of USFDA-approved manufacturing capacity to Natco Pharma&#8217;s revenue base, the company&#8217;s regulatory compliance track record is a key monitoring point for investors.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Natco Pharma share price and USFDA regulatory updates live.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Natco Pharma share price rose 0.36% to Rs 885.70 on August 24, 2026, despite the company disclosing four USFDA observations at its Visakhapatnam FDF manufacturing plant following an inspection from August 17 to 21. The company has characterised the observations as procedural in nature, and the muted market reaction suggests investors view this as a manageable regulatory matter. Monitor for the company&#8217;s formal response to the FDA and any subsequent regulatory classification. Verify all data on NSE and BSE before making any investment decisions.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Natco_Pharma_USFDA_inspection_at_Visakhapatnam\"><\/span><strong>What is the Natco Pharma USFDA inspection at Visakhapatnam?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The US FDA inspected Natco Pharma&#8217;s Finished Dosage Formulations (FDF) manufacturing plant in Visakhapatnam, Andhra Pradesh, from August 17 to 21, 2026, and issued a Form 483 with four observations, which the company has described as procedural in nature.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Natco_Pharma_share_price_today\"><\/span><strong>What is Natco Pharma share price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Natco Pharma was trading at Rs 885.70 on August 24, 2026, up 0.36% or Rs 3.20. Intraday high was Rs 892.40 and intraday low was Rs 876.90.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Natco_Pharma_share_price_rise_despite_FDA_observations\"><\/span><strong>Why did Natco Pharma share price rise despite FDA observations?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Natco Pharma share price rose modestly despite the FDA observations because the market assesses procedural Form 483 observations as routine and manageable, unlike a more serious Warning Letter or OAI classification. Trading volume was also slightly below average, suggesting limited market urgency.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_a_Form_483_in_FDA_inspections\"><\/span><strong>What is a Form 483 in FDA inspections?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> A Form 483 is a document issued by the US FDA at the conclusion of an inspection when investigators observe conditions that may constitute violations of the Food, Drug, and Cosmetic Act. Companies have the opportunity to respond with corrective action plans within a standard timeline.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Natco_Pharmas_business\"><\/span><strong>What is Natco Pharma&#8217;s business?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Natco Pharma is a leading Indian pharmaceutical company known for its complex generics portfolio, oncology drug franchise, and API manufacturing. It operates multiple USFDA-certified manufacturing facilities supplying finished dosage formulations to regulated global markets.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Natco_Pharma_a_good_buy_after_the_USFDA_observations\"><\/span><strong>Is Natco Pharma a good buy after the USFDA observations?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This article is for educational purposes only and is not investment advice. Procedural observations are generally manageable, but investors should monitor the company&#8217;s formal FDA response and any subsequent regulatory classification changes. Consult a SEBI-registered advisor before investing.<\/p>\n<div class=\"faq-schema\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Natco Pharma share price rose 0.36% to Rs 885.70 on August 24, 2026, even as USFDA issued four procedural observations at its Visakhapatnam FDF manufacturing plant following an August 17-21 inspection. Muted market reaction suggests manageable regulatory matter.<\/p>\n","protected":false},"author":36,"featured_media":217105,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[3802],"class_list":["post-217106","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["217105"],"_edit_lock":["1787560925:36"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["24"],"rank_math_seo_score":["76"],"rank_math_title":["Natco Pharma Share Price Up 0.36% Despite 4 USFDA Observations at Visakhapatnam Plant"],"rank_math_description":["Natco Pharma share price rose 0.36% to Rs 885.70 on August 24, 2026, even as USFDA issued four procedural observations at its Visakhapatnam FDF plant following an August 17-21 inspection."],"rank_math_focus_keyword":["Natco Pharma share price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_edit_last":["36"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["39551"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/natco-pharma-share-price-usfda-observations-visakhapatnam-august-2026.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/217106","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/36"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=217106"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/217106\/revisions"}],"predecessor-version":[{"id":217113,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/217106\/revisions\/217113"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/217105"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=217106"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=217106"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=217106"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}